Literature DB >> 9130951

Zolpidem in Parkinson's disease.

A Daniele, A Albanese, G Gainotti, B Gregori, P Bartolomeo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130951     DOI: 10.1016/S0140-6736(05)62416-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  High-dose zolpidem withdrawal seizure in a patient with spinocerebellar ataxia.

Authors:  Cheng-Chen Chang; Wen-Fang Wang
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases.

Authors:  Thomas J Feuerstein; Miriam Kammerer; Carl Hermann Lücking; Andreas Moser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

3.  Treatment of Isolated Dystonia with Zolpidem.

Authors:  Yoshimichi Miyazaki; Hidetaka Koizumi; Ryosuke Miyamoto; Toshitaka Kawarai; Ryuji Kaji
Journal:  Mov Disord Clin Pract       Date:  2015-12-18

Review 4.  Progressive supranuclear palsy: clinical features, pathophysiology and management.

Authors:  A Rajput; A H Rajput
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

Review 6.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 7.  Treatment of the sleep disorders associated with Parkinson's disease.

Authors:  Lynn Marie Trotti; Donald L Bliwise
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

8.  Efficacy of zolpidem for dystonia: a study among different subtypes.

Authors:  Yoshimichi Miyazaki; Wataru Sako; Kotaro Asanuma; Yuishin Izumi; Tetsuro Miki; Ryuji Kaji
Journal:  Front Neurol       Date:  2012-04-17       Impact factor: 4.003

9.  Novel L-Dopa and dopamine prodrugs containing a 2-phenyl-imidazopyridine moiety.

Authors:  Nunzio Denora; Valentino Laquintana; Angela Lopedota; Mariangela Serra; Laura Dazzi; Giovanni Biggio; Dhananjay Pal; Ashim K Mitra; Andrea Latrofa; Giuseppe Trapani; Gaetano Liso
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.580

10.  A case with improvement of blepharospasm by zolpidem.

Authors:  Munkyung Sunwoo; Junghee Cho; Jun Hong Lee; Gyu Sik Kim; Jong Hun Kim; Sun-Ah Choi
Journal:  J Mov Disord       Date:  2011-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.